On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of ...

The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...

UW Health's Dr. Bill Hartman discusses a study that warned of "widespread" iron deficiency, the relationship between ...

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...

The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...

The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.

US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...

People with Parkinson's disease (PD) who experience visual hallucinations have reduced brain responses to unexpected visual changes, a marker known as visual mismatch negativity (vMMN).

A slew of legal and procedural processes are expected to play out ahead of Jospeh Corcoran’s scheduled execution on Dec. 18.

Prison staff said there was no "clear information" that Shane Richard Davies was showing symptoms before his death and that ...